The Dorsomorphin Dihydrochloride Market is anticipated to grow significantly in the forecast period from 2022 to 2028. Dorsomorphin dihydrochloride (BML-275 dihydrochloride, compound C dihydrochloride) is a potent, selective, ATP-competitive AMPK inhibitor with a Ki of 109 nM. Dorsomorphin dihydrochloride inhibits the BMP pathway by targeting the type I receptors ALK2, ALK3, and ALK6. Dorsomorphin dihydrochloride […]
